Bapir R, Bhatti KH, Eliwa A, García-Perdomo HA, Gherabi N, Hennessey D, Magri V, Mourmouris P, Ouattara A, Perletti G, Philipraj J, Stamatiou K, Tolani MA, Tzelves L, Anker SD, Trinchieri A, Buchholz N. Risk of urogenital infections in non-diabetic patients treated with sodium glucose transporter 2 (SGLT2) inhibitors. Systematic review and meta-analysis. Arch Ital Urol Androl [Internet]. 2023 Jun. 13 [cited 2024 Nov. 23];95(2). Available from: https://www.pagepressjournals.org/aiua/article/view/11509